RG
Insider
Ramiro Guerrero
DirectorRamiro Guerrero (Director) filed 3 Form 4 reports in the past 24 months (3 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in MAIA Biotechnology, Inc. (MAIA). Across 2 priced purchase filings, the average 21-session return was -16.8% from execution and -16.4% from disclosure (delay-adjusted; derived). The largest single filing was $222K of MAIA (88,534 sh × $2.51, as filed), executed Nov 1 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-16.8%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-16.4%
same 2 filings, from disclosure
Filings, ttm
3
3 buys · 0 sells · 1 late
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$442K
shares × price, as filed
Last traded
Feb 24 2025
Filed Feb 25 2025
Median ADV $915K across their filed names
Open performance→Volume by month
Buys $442K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 24 months
Most traded names
MAIARecent filings
MAIAPURCHASE
MAIA Biotechnology, Inc.
View filing →
$110K73,333 sh × $1.50
Exec Feb 24 2025
Filed Feb 25 2025 · 5:30 PM ET MAIAPURCHASE MAIA Biotechnology, Inc. View filing → $110K
73,333 sh × $1.50
Exec Feb 24 2025
Filed Mar 5 2025 · 5:30 PM ET † MAIAPURCHASE MAIA Biotechnology, Inc. View filing → $222K
88,534 sh × $2.51
Exec Nov 1 2024
Filed Nov 4 2024 · 5:30 PM ET